 |
|
|
|
|
Product Details:
Payment & Shipping Terms:
|
| Name: | TAK438， Vonoprazan Fumarate | CAS: | 1260141-27-2 |
|---|---|---|---|
| Purity: | 99.5% | Appearance: | White Powder |
| Packing: | 1kg/Bag,10kg/Drum,25kg/Drum Or As Required | MF: | C21H20FN3O6S |
| MOQ: | 1KG | ||
| High Light: | TAK-438 Vonoprazan Fumarate,CAS 1260141-27-2,99.5% Purity Vonoprazan Fumarate |
||
Vonoprazan Fumarate (Synonyms: TAK-438)CAS NO.:1260141-27-2 with High Purity 99.0%Min.
API Material Cas1260141-27-2 Vonoprazan Fumarate TAK438 Powder
| Product Name | Vonoprazan Fumarate |
| Appearance | White powder |
| Assay | 99%min, 98.0% --101.0% |
| Test | HPLC |
| Certificate | ISO 9001 |
| CAS | 1260141-27-2 |
| MF | C21H20FN3O6S |
| Storage Temperature | Cool Dry Place |
Vonoprazan can be used for the treatment of gastroduodenal ulcer (including some drug-induced peptic ulcers) and reflux esophagitis, and can be combined with antibiotics for the eradication of Helicobacter pylori.
Vonoprazan fumarate shows strong and sustainable acid secretion inhibitory effects as well as demonstrate efficacy in early termination by inhibiting the binding of potassium ion (K+) to H+, K+-ATPase (proton pump) in the final step of gastric acid secretion in gastric parietal cells.
Color:White powder
Purity:99%min
Usage: Pharmaceutical intermediates
Delivery Detail:Shipped in 3 days after payment
| Anticancer | |||
| Azd-9291 Mesylate/Osimertinib | 1421373-66-1 | XL-184 Malate/Cabozantinib Malate | 1140909-48-3 |
| E7080 Mesylate/Lenvatinib Mesylate | 857890-39-2 | AZD6244/ Selumetinib | 606143-52-6 |
| AZD3759 | 1626387-80-1 | INC280/Benzamide | 1029712-80-8 |
| Vemurafenib | 918504-65-1 | Neratinib | 698387-09-6 |
| Dabrafenib Mesylate | 1195768-06-9 | Olaparib | 763113-22-0 |
| MK1775 | 955365-80-7 | Crizotinib | 877399-52-5 |
| AP26113 | 1197958-12-5 | LY 2157299/Galunisertib | 700874-72-2 |
Contact Person: July
Tel: 25838890
